Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
종목 코드 NUWE
회사 이름Nuwellis Inc
상장일Feb 16, 2012
설립일2002
CEOErb (John L)
직원 수38
유형Ordinary Share
회계 연도 종료Feb 16
주소12988 Valley View Rd
도시EDEN PRAIRIE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호55344
전화19523454200
웹사이트https://www.nuwellis.com/
종목 코드 NUWE
상장일Feb 16, 2012
설립일2002
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음